Zephyrus Biosciences Company

Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Addressing the burgeoning single-cell analysis market, our first product, the scWestern system, enables western blotting on individual cells for the first time. Researchers will utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development.

Founded Date: 2013-01-01
Total Funding: $1.9M
Investor Type: For Profit
Employee Number: 1-10
Funding Status: M&A
Number Of Exists: Seed
Technology: Regenerative Medicine
Last Funding Type: Seed
Investors Number: 10
Industry: Biotechnology, Hardware, Health Care
Headquarters: Berkeley, California, United States